Abstract

Identification of screening tests for the detection of head and neck cancer at an early stage is an important strategy to improving prognosis. Our objective was to identify plasma circulating microRNAs for the diagnosis of head and neck cancer (oral and laryngeal subsites), within a multicenter International Head and Neck Cancer Epidemiology (INHANCE) consortium.
Lingua originaleEnglish
pagine (da-a)1-7
Numero di pagine7
RivistaCancer Epidemiology Biomarkers and Prevention
Volume2022
Numero di pubblicazione13
DOI
Stato di pubblicazionePubblicato - 2022

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2700???

Keywords

  • head and neck

Fingerprint

Entra nei temi di ricerca di 'Plasma miR-151-3p as a candidate diagnostic biomarker for head and neck cancer: a cross-sectional study within the INHANCE consortium'. Insieme formano una fingerprint unica.

Cita questo